Abstract
Borderline ovarian tumours are clinical entities less frequently encountered by obstetricians
and gynecologists. Management options keep on changing with time and fertility sparing
procedures and laparoscopy keep emerging. Surgical removal of all visible tumours
still remains the most effective management. So far, non surgical treatment modalities
have not been found to be beneficial. Pathologists are increasingly able to identify
poor prognostic features in histology. Molecular biological studies are progressively
being elucidated as prognostic features which might help us more in understanding
the carcinogenic process and progression of the disease. This review outlines the
recent literature regarding pathology, diagnosis, treatment, prognosis and recurrence.
Oncologic concerns are discussed with emphasis on mode of surgery, fertility sparing
surgery and the outcomes.